Synthesis of 2-oxomethylcytisine derivatives with nootropic activity

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

A library of 2-oxomethylcytisine derivatives, including conjugates with a phenyl fragment linked to the starting molecule via aminomethyl, acyl, ethenyl, ethyl, thio-, and carboxamide, as well as propenone spacers, has been synthesized. This library also includes Diels–Alder adducts with N-substituted maleinimides. The nootropic activity of the synthesized compounds was studied in vivo using the CPAR test. Three samples were found to have comparable or superior activity to the reference drug Piracetam (the latent period for the first entry of laboratory animals into the dark chamber at the stage of reflex reproduction was 271.7±50.3, 288.8±50.8 and 300.0±0.0 seconds versus 270.9±29.1 seconds, respectively).

全文:

受限制的访问

作者简介

A. Koval’skaya

Ufa Federal Research Center of Russian Academy of Sciences

Email: tsypysheva.ip@gmail.com
ORCID iD: 0000-0001-7772-2894

Ufa Institute of Chemistry

俄罗斯联邦, Ufa, 450054

V. Sorokina

Ufa Federal Research Center of Russian Academy of Sciences

Email: tsypysheva.ip@gmail.com
ORCID iD: 0000-0001-5311-9580

Ufa Institute of Chemistry

俄罗斯联邦, Ufa, 450054

N. Makara

Ufa Federal Research Center of Russian Academy of Sciences

Email: tsypysheva.ip@gmail.com
ORCID iD: 0000-0002-1334-1504

Ufa Institute of Chemistry

俄罗斯联邦, Ufa, 450054

R. Khisamutdinova

Ufa Federal Research Center of Russian Academy of Sciences

Email: tsypysheva.ip@gmail.com
ORCID iD: 0000-0003-3477-4250

Ufa Institute of Chemistry

俄罗斯联邦, Ufa, 450054

S. Gabdrakhmanova

Ufa Federal Research Center of Russian Academy of Sciences

Email: tsypysheva.ip@gmail.com
ORCID iD: 0000-0002-6902-775X

Ufa Institute of Chemistry

俄罗斯联邦, Ufa, 450054

I. Tsypysheva

Ufa Federal Research Center of Russian Academy of Sciences

编辑信件的主要联系方式.
Email: tsypysheva.ip@gmail.com
ORCID iD: 0000-0002-5025-8742

Ufa Institute of Chemistry

俄罗斯联邦, Ufa, 450054

参考

  1. Armstrong R. // Folia Neuropathol. 2020. Vol. 58. N 2. P. 93. doi: 10.5114/fn.2020.96707.
  2. Jomova K., Vondrakova D., Lawson M., Valko M. // Mol. Cell. Biochem. 2010. Vol. 345. P. 91. doi: 10.1007/s11010-010-0563-x
  3. Cristidi F., Migliaccio R., Santamaria-Garcia H., Santangelo G., Trojsi F. // Behav. Neurol. 2018. P. 1849794. doi: 10.11155/2018/1849794
  4. Teixeira A.L., Gregg A., Gentry M.T., Gujral S., Rapp E., Oberlin L., Ajilore O., Weisenbach S., Patrick R. // Focus (Am. Psychiatr. Publ.). 2025. Vol. 23. N 2. P. 183. doi: 10.1176/appi.focus.20240046
  5. Nys G.M.S., Van Zandvoort M.J.E., De Kort P.L.M., Jansen B.P.W., De Haan E.H.F., Kappelle L. J. // Cerebrovasc. Dis. 2007. Vol. 23. P. 408. doi: 10.1159/000101464
  6. Li H., Ke X., Feng B., Tian H., Cai Zh., Zhang A., Man Q. // Front. Endocrinol. 2025. Vol. 16. P. 1500650. doi: 10.3389/fendo.2025.15000650
  7. Johansen M.C., Langton-Frost N., Gottesman R.F. // Curr. Geriatr. Rep. 2020. Vol. 9. N 1. P. 1. doi: 10.1007/s13670-020-00309-7
  8. Pedersen E.M., Köhler-Forsberg O., Nordentoft M., Christensen R.H., Mortensen P.B., Petersen L., Benros M.E. // Brain Behav. Immun. 2020. Vol. 88. P. 668. doi 10.1016/ j.bbi.2020.04.072
  9. Gariani K., Ryu D., Rizzo M. // Front. Clin. Diabetes Healthc. 2025. Vol. 6. P. 1534105. doi 10.3389/ fcdhc.2025.1534105
  10. Hansen N. // Behav. Brain. Res. 2025. Vol. 482. P. 115460. doi: 10.1016/j.bbr.2025.115460
  11. Enciu A.M., Nicolescu M.I., Manole C.G., Mureşanu D.F., Popescu L.M., Popescu B.O. // BMC Neurol. 2011. Vol. 11. P. 1. doi: 10.1186/1471-2377-11-75
  12. Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. // Nat. Rev. Neurol. 2019. Vol. 15. N 10. P. 565. doi: 10.1038/s41582-019-0244-7
  13. Kopalli S.R., Behl T., Baldaniya L., Ballal S., Joshi K.K., Arya R., Chaturvedi B., Chauhan A.S., Verma R., Patel M., Jain S.K., Wal A., Gulati M., Koppula S. // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2025. Vol. 139. P. 111375. doi: 10.1016/j.pnpbp.2025.111375
  14. Cao W., Zhu B., Liu Zh., Jia X., Zhao H., Gu N., Chang H., Xi J., Li R., Guo K. // Neuroscience. 2025. Vol. 565. P. 29. doi: 10.1016/j.neuroscience.2024.11.029
  15. Машковский М. Д. Лекарственные средства. М.: Новая волна, 2012. 1216 с.
  16. Ji M., Niu S.Q., Mi H.Y., Jiang P., Li Y. // Chem. Biol. Drug Des. 2024. Vol. 103. P. e14358. doi: 10.1111/cbdd.14358
  17. Fernandes D., Suryadevara U., Bruijnzeel D., Cheong J. // Curr. Psychiatry Rep. 2024. Vol. 26. N 3. P. 73. doi: 10.1007/s11920-024-01484-6
  18. Hossna J.A., Das S.K., Azman N., Syafiqah B.N. // World J. Pharm. Pharm. Sci. 2024. Vol. 13. N 6. P. 1. doi: 10.20959/wjpps20246-27384
  19. Daly J.W. // Cell. Mol. Neurobiol. 2005. Vol. 25. N 3–4. P. 513. doi: 10.1007/s10571-005-3968-4
  20. Gotti C., Clementi F. // Pharmacol. Res. 2021. Vol. 170. P. 105700. doi: 10.1016/j.phrs.2021.105700
  21. Huang X., Xu H. // Mini Rev. Med. Chem. 2020. Vol. 20. P. 369. doi: 10.2174/1389557519666191104121821
  22. Cely-Veloza W., Kato M.J., Coy-Barrera E. // ACS Omega. 2023. Vol. 8. N 31. P. 27862. doi: 10.1021/acsomega.3c02179
  23. Wang X., Yang J., Huang P., Wang D., Zhang Z., Zhou Z., Liang L., Yao R., Yang L. // Biomed. Pharmacother. 2024. Vol. 171. P. 116210. doi: 10.1016/j.biopha.2024.116210
  24. Tedesco E., Ceccato S., Torazzi A., Santin L., Losso L., Bottardi A., Casari R., Melvhiori S., Secchettin E., Ferrero V., Arzenton E., Marini P., Lugoboni F., Chiamulera C. // Int. Emerg. Med. 2025. Vol. 20. P. 817. doi: 10.1007/s11739-025-03888-5
  25. Mills K.A., Kuwabara H., Du Y., Gomez G., Motley Ch.S., Skorobogatova Y., Spiro E., Coughlin J.M., Lesniak W., Brandt J., Kamath V., Pomper M.G., Smith G.S. // J. Parkinsons Dis. 2025. Vol. 15. N 2. P. 374. doi: 10.1177/18777I8X241313373
  26. Sabec M.H., Savage Q.R., Wood J.L., Maskos U. // Mol. Psychiatry. 2025. Vol. 30. P. 556. doi: 10.1038/s41380-024-02666-7
  27. Ota H., Ohnuma T., Kodama A.., Shimizu T, Sugawara K., Yamamoto F. // Cells. 2025. Vol. 14. N 5. P. 340. doi: 10.3390/cells14050340
  28. ElNebrisi E., Lozon Y., Oz M. // Int. J. Mol. Sci. 2025. Vol. 26. N 7. P. 3210. doi: 10.3390/ijms26073210
  29. Tsypysheva I.P., Koval’skaya A.V., Makara N.S., Lobov A.N., Petrenko I. A., Galkin E.G., Sapozhnikova T.A., Zarudii F.S., Yunusov M.S. // Chem. Nat. Compd. 2012. Vol. 48. N 4. P. 629. doi: 10.1007/s10600-012-0329-7
  30. Tsypysheva I.P., Koval’skaya A.V., Lobov A.N., Salimgareeva M.Kh., Fatkullina U.Sh., Petrova P.R., Gabdrakhmanova S.F., Makara N.S., Suponitskii K.Yu., Vakhitova Yu.V., Zarudii F.S., Yunusov M.S. // Chem. Nat. Compd. 2013. Vol. 49. N 4. P. 707. doi: 10.1007/s10600-013-0713-y
  31. Tsypysheva I., Petrova P., Koval’skaya A., Lobov A., Sapozhnikova T., Makara N., Gabdrakhmanova S., Zarudii F. // Nat. Prod. Res. 2021. Vol. 35. P. 207. doi: 10.1080/14786419.2019.1622106
  32. Makara N.S., Sapozhnikova T.A., Khisamutdinova R.Y., Tsypysheva I.P., Borisevich S.S., Kovalskaya A.V., Petrova P.R., Khursan S.L., Zarudii F.S. // Bull. Exp. Biol. Med. 2018. Vol. 164. P. 434. doi: 10.1007/s10517-018-4006-0
  33. Koval’skaya A.V., Lobov A.N., Sorokina V.A., Tsypysheva I.P., Dokichev V.A. // Chem. Nut. Compd. 2023. Vol. 59. P. 738. doi: 10.1007/s10600-023-04099-0
  34. Koval’skaya A.V., Lobov A.N., Tsypyshev D.O., Lin Ch.V., Tsypysheva I.P. // Chem. Nat. Compd. 2020. Vol. 60. P. 683. doi: 10.1007/s10600-024-04411-6
  35. Petrova P.R., Kovalskaya A.V., Lobov A.N., Tsypysheva I.P. // Nat. Prod. Res. 2019. Vol. 33. P. 1897. doi: 10.1080/14786419.2018.1478832
  36. Giuliano R.M., Buzby J.H., Marcopulos N., Springer J.P. // J. Org. Chem. 1990. Vol. 55. P. 3555. doi: 10.1021/jo00298a033
  37. Tsypysheva I.P., Borisevich S.S., Lobov A.N., Kovalskaya A.V., Shamukaev V.V., Safiullin R.L., Khursan S.L. // Tetrahedron: Asym. 2015. Vol. 26. P. 732. doi 10.1016/ J.TETASY.2015.06.005
  38. Ковальская А.В., Цыпышева И.П., Хурсан С.Л., Сафиуллин Р.Л. // Вестн. Баш. унив. 2021. Т. 26. C. 695. doi: 10.33184/bulletin-bsu-2021.3.28
  39. Posner G.H., Vinader V., Afarinkia K. // J. Org. Chem. 1992. Vol. 57. P. 4088. doi: 10.1016/S0040-4020(01)85607-6
  40. Миронов А.Н. Руководство по проведению доклинических исследований лекарственных средств. М.: Гриф и К, 2012. Ч. 1. 944 с.
  41. Taherianfard M., Ahmadijokani S. // Brain Behav. 2023. Vol. 13. N 4. P. e2942. doi: 10.1002/brb3.2942
  42. Inozemtsev A.N., Berezhnoy D.S., Novoseletskaya A.V. // Moscow Univ. Biol. Sci. Bull. 2019. Vol. 74. P. 215. doi: 10.3103/S0096392519040047
  43. Тюренков И.Н., Бородкина Л.Е., Воронков А.В. // Вестн. ВолгГМУ. 2004. № 11. С. 24.
  44. Tikhonov V.N., Komissarov I.V., Volobuev V.V. // Neurophysiology. 2003. Vol. 35. P. 24. doi: 10.1023/A:1023942121847

补充文件

附件文件
动作
1. JATS XML
2. Scheme 1. 1a, R = H [(−)-cytisine] 1b, R = Me (methylcytisine) 2a, X = O, X1 = H,H, R = Me 2b, X = H,H, X1 = O, R = Me 2c, X = O, X1 = H,H, R = CH=CH(CO)Ph 2g, X = O, X1 = H,H, R = NH2 2d, X = O, X1 = H,H, R = NHCH2Ph 2е, X = O, X1 = H,H, R = NH(CO)Ph 2g, X = O, X1 = H,H,R = NH(CO)NHPh 2з, X = O, X1 = H,H,R = NH(CS)NHPh 2i, X = O, X1 = H,H,R = Ph 2k, X = O, X1 = H,H,R = CH=CHPh 2l, X = O, X1 = H,H,R = CH2CH2Ph 3a, X = O, X1 = H,H, R1 = i-Pr 3b, X = O, X1 = H,H, R1 = n-Pr 3c, X = O, X1 = H,H, R1 = Ph 3d, X = O, X1 = H,H, R1 = 2-MeO-Ph 3d: X = O, X1 = H,H, R1 = 3-MeO-Ph 3e, X = H,H, X1 = O, R1 = i-Pr

下载 (391KB)
3. Scheme 2. Reagents and conditions: i, KMnO4, acetone, 20°C; ii, 3 eq. N-isopropylmaleimide, toluene, 110°C; iii, methenamine, CF3COOH, 70°C; iv, C6H5COCH3, NaOH (10%), H2O, 20°C.

下载 (711KB)
4. Scheme 3.

下载 (578KB)
5. Scheme 4.

下载 (373KB)

版权所有 © Russian Academy of Sciences, 2025